Intelligent response type chitosan gel system and preparation method thereof

By introducing reactive oxygen-responsive nanomedicated liposomes and sodium glycerol phosphate into chitosan gel, an intelligent responsive gel was formed, which solved the problem that traditional arthritis treatment methods could not effectively inhibit the progress of osteoarthritis, and achieved The dual-functional therapeutic effect of rapid response to reactive oxygen species, reduced friction and slow release of drugs has been significantly improved in arthritis symptoms and cartilage repair.

CN119055584APending Publication Date: 2024-12-03HANGZHOU SINGCLEAN MEDICAL PROD

Patent Information

Application Number
CN202411569517.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-11-05
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Traditional arthritis treatment methods cannot effectively inhibit the progress of osteoarthritis, especially the anti-inflammatory, friction and chondrocyte regeneration problems on the surface of the cartilage have not been systematically solved, and poor drug compliance and strong side effects of drug metabolism.

Method used

An intelligent responsive chitosan gel system was designed to form multifunctional water with controlled release, self-lubricating, anti-inflammatory and antioxidant by introducing reactive oxygen-responsive nanomedicated liposomes using charge adsorption. The gel system combines sodium glycerol phosphate and strong alkali and weak acid salt solution to achieve the treatment of arthritis and cartilage repair.

Benefits of technology

The gel system can quickly respond to reactive oxygen species in the joint cavity, eliminate inflammation, reduce MMP13 degradation enzymes, promote cartilage differentiation, reduce friction, delay arthritis progression, and achieve dual-functional therapeutic effects by slowly releasing drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119055584A_ABST
    Figure CN119055584A_ABST
Patent Text Reader

Abstract

The invention relates to intelligent response type chitosan gel and a preparation method thereof. The intelligent response type chitosan gel is prepared from active oxygen response type lipidosome, a chitosan solution, a sodium glycerophosphate solution, a medicine and the like. According to the invention, a drug-loaded liposome with active oxygen response is introduced, and a nanoliposome with negative electricity is loaded into chitosan-sodium glycerophosphate gel in a charge adsorption manner, so that a response type multifunctional composite hydrogel system is prepared. After the intelligent response drug-loaded hydrogel system is injected into a human body, gel is formed in situ, the lubricating capacity of the hydrogel system is enhanced through introduction of lipidosome, and friction force in an articular cavity is reduced. Meanwhile, the liposome can be split through the process of removing active oxygen, and the medicine is controlled in the articular cavity in a controlled release manner. Therefore, the intelligent gel can delay the progress of arthritis through the synergistic effect of lubrication, oxidation resistance and inflammation resistance.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of biomaterial preparation and discloses an intelligent responsive chitosan gel system and a preparation method thereof. Background Art

[0002] In the traditional treatment of arthritis, simply relying on oral analgesics can relieve osteoarthritis symptoms in the short term, but it faces problems such as poor patient compliance, continuous medication, and strong drug metabolism side effects. Moreover, these treatment strategies do not systematically address the anti-inflammatory, friction, or chondrocyte regeneration problems on the cartilage surface, and cannot fundamentally solve the failure of the overall joint system and meet the needs of patients. Osteoarthritis is a secondary disease that involves multiple pathological processes, including synovial inflammation, cartilage degeneration, etc., during which the coordinated interactions of multiple cells and signal pathways accelerate the progression of osteoarthritis. Therefore, how to design an adjustable joint microenvironment biomaterial system is of great scientific significance for inhibiting the progressive aggravation of osteoarthritis.

[0003] Chitosan hydrogel is a marine-derived biomaterial with good biocompatibility, adjustable physical properties, inflammation inhibition, lubrication and other advantages, providing a new idea for the treatment of osteoarthritis. The present invention introduces nano drug-loaded liposomes with active oxygen response on the basis of traditional chitosan gel, which can remove active oxygen, delay the release of drugs, improve the lubrication effect of the gel system, and further improve the therapeutic effect of the chitosan gel system. Summary of the invention

[0004] The purpose of the present invention is to provide an intelligent responsive chitosan gel system and a preparation method thereof, which forms a multifunctional intelligent hydrogel system with drug controlled release, self-lubrication, anti-inflammatory and anti-oxidation by charge adsorption, so as to achieve the treatment of joint inflammation and cartilage repair. The present invention is achieved by the following technical solutions: The invention discloses an intelligent response type chitosan gel system. The components of the chitosan gel system include active oxygen response drug-loaded liposomes, chitosan, sodium glycerophosphate and strong base and weak acid salt solutions.

[0005] As a further improvement, the volume ratio of the chitosan solution, the sodium glycerophosphate solution, and the active oxygen responsive drug-loaded liposomes described in the present invention is (1-30): (0.1-3): (0-2).

[0006] The invention discloses a method for preparing an intelligent responsive chitosan gel system, comprising the following steps: 1) The reactive oxygen species-responsive liposome precursor, phospholipids and cholesterol are prepared into reactive oxygen species-responsive liposomes by thin film hydration method; 2) The reactive oxygen species responsive liposomes are loaded with water-soluble anti-inflammatory drugs into the liposomes by the pH gradient method to obtain reactive oxygen species responsive drug-loaded liposomes; 3) dissolving chitosan completely in an acid solution to obtain a chitosan solution, and dissolving sodium glycerophosphate in an aqueous solution containing a strong base and a weak acid salt to obtain a sodium glycerophosphate solution; 4) Under ice bath conditions, sodium glycerophosphate solution was added dropwise to the chitosan solution, and then active oxygen responsive drug-loaded liposomes were added and loaded into the gel by charge adsorption, finally obtaining an intelligent responsive chitosan gel system.

[0007] As a further improvement, the active oxygen responsive liposome precursor described in the present invention is distearoylphosphatidylethanolamine and polyethylene glycol modified with thioketal; the phospholipid is an anionic phospholipid, one or more of distearoylphosphatidylcholine, distearoylphosphatidylglycerol, distearoylphosphatidylethanolamine, and dipalmitoylphosphatidylcholine; the molar ratio of phospholipid, liposome precursor, and cholesterol in the active oxygen responsive liposome is (50%~95%): (1%~20%): (1%~20%).

[0008] As a further improvement, the molecular weight of the chitosan described in the present invention is 10,000-1,900,000 Da, the deacetylation degree of the chitosan is 45%-90%, and the concentration of the chitosan solution is 0.5%-2.5%.

[0009] As a further improvement, in step 3) of the present invention, the sodium glycerophosphate is one or more of α-sodium glycerophosphate and β-sodium glycerophosphate, and the concentration is 5% to 70%.

[0010] As a further improvement, in step 3) of the present invention, the strong base and weak acid salt solution is one or more of sodium carbonate, sodium bicarbonate, sodium hydrogen phosphate, and disodium hydrogen phosphate, and the concentration is 0.01-0.4 mol / L.

[0011] As a further improvement, the chitosan solution in step 3) of the present invention is chitosan dissolved in one or more of hydrochloric acid, acetic acid, and formic acid solutions, and the acid concentration is 0.01-0.4 mol / L.

[0012] As a further improvement, in step 4) of the present invention, the sodium glycerophosphate solution is added dropwise to the chitosan solution under ice bath conditions, and the sodium glycerophosphate solution is added dropwise to the chitosan solution under ice-water mixed bath conditions and stirred for 5-30 minutes.

[0013] As a further improvement, the concentration of the active oxygen responsive drug-loaded liposomes of the present invention is calibrated by high performance liquid chromatography using the loaded drug, and the concentration is 0.01-1000 μg / ml.

[0014] Compared with the prior art, the innovation and beneficial effects of the present invention are mainly reflected in: (1) In the present invention, anionic phospholipids are used to prepare negatively charged active oxygen responsive drug-loaded liposomes, which are loaded into positively charged chitosan hydrogels by charge adsorption to prepare smart responsive chitosan hydrogel systems.

[0015] (2) The level of reactive oxygen species in the joint cavity in the arthritis microenvironment increases. The intelligent responsive chitosan hydrogel system can respond quickly and sensitively to reactive oxygen species, remove reactive oxygen species, relieve inflammation in the joint cavity, reduce MMP13 degradation enzymes, and promote cartilage differentiation.

[0016] (3) The present invention introduces active oxygen-responsive drug-loaded liposomes, which can continuously release lipids to rebuild the boundary layer as the hydrogel degrades, thereby enhancing the lubrication ability of the gel system, reducing the friction in the joint cavity, and thus delaying arthritis.

[0017] (4) The present invention introduces active oxygen-responsive drug-loaded liposomes, which can fully release the loaded drugs while scavenging active oxygen, thereby achieving dual functions at the same time.

[0018] (5) The intelligent responsive chitosan hydrogel system prepared by the present invention can achieve the slow release of drug molecules through intra-articular injection, and effectively delay the progression of arthritis through the synergistic effects of lubrication, anti-oxidation and anti-inflammation.

[0019] (6) The present invention relates to a method for preparing an intelligent responsive chitosan hydrogel system, which is composed of active oxygen responsive drug-loaded liposomes, chitosan solution, sodium glycerophosphate solution, etc. The chitosan hydrogel system prepared by the present invention can respond to active oxygen, reduce the friction in the joint cavity, achieve a self-lubricating effect, and delay the development of arthritis through the sustained release of drug-loaded molecules.

[0020] (7) In the present invention, sodium glycerophosphate is dissolved in an aqueous solution containing a strong base and a weak acid salt to obtain a sodium glycerophosphate solution. The introduction of the strong base and the weak acid salt can accelerate the gelation time of the smart responsive chitosan hydrogel system.

[0021] (8) In the present invention, the volume ratio of chitosan solution, sodium glycerophosphate solution, and active oxygen responsive drug-loaded liposomes is (1-30): (0.5-3): (0-2), which can adjust the osmotic pressure of the smart responsive chitosan hydrogel system and match it to the osmotic pressure of the joint cavity. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 (a) is the TEM image of nanoliposomes in an active oxygen environment; (b) is the Zeta potential image of nanoliposomes; (c) is the particle size characterization image of active oxygen responsive nanoliposomes; (d) is the particle size image of nanoliposomes in an active oxygen environment.

[0023] Figure 2 (a) is a schematic diagram of the morphology of chitosan hydrogel; (b) is a schematic diagram of the morphology of the smart responsive chitosan gel system.

[0024] Figure 3 Schematic diagram of the friction force comparison among sodium hyaluronate gel, chitosan hydrogel, and smart responsive chitosan gel system.

[0025] Figure 4 Cell activity diagram of chitosan hydrogel and smart responsive chitosan gel system.

[0026] Figure 5 This is a diagram of the drug release characteristics of the liposome-loaded chitosan hydrogel system. DETAILED DESCRIPTION

[0027] The invention discloses an intelligent response chitosan gel system. The components of the chitosan gel system include active oxygen response drug-loaded liposomes, chitosan, sodium glycerophosphate and strong base and weak acid salt solutions; the volume ratio of the chitosan solution, the sodium glycerophosphate solution and the active oxygen response drug-loaded liposomes is (1-30): (0.1-3): (0-2).

[0028] The present invention also discloses a method for preparing an intelligent responsive chitosan gel system, comprising the following steps: 1) The reactive oxygen responsive liposome precursor, phospholipid and cholesterol are prepared into reactive oxygen responsive liposomes by thin film hydration method; the reactive oxygen responsive liposome precursor is distearoylphosphatidylethanolamine and polyethylene glycol modified with thioketal; the phospholipid is an anionic phospholipid, one or more of distearoylphosphatidylcholine, distearoylphosphatidylglycerol, distearoylphosphatidylethanolamine and dipalmitoylphosphatidylcholine; the molar ratio of phospholipid, reactive oxygen responsive liposome precursor and cholesterol in the reactive oxygen responsive liposome is (50%~95%): (1%~20%): (1%~20%); the strong base and weak acid salt solution is one or more of sodium carbonate, sodium bicarbonate, sodium hydrogen phosphate and disodium hydrogen phosphate, and the concentration is 0.01~0.4 mol / L.

[0029] 2) The reactive oxygen species responsive liposomes are loaded with water-soluble anti-inflammatory drugs into the liposomes through the pH gradient method to obtain reactive oxygen species responsive drug-loaded liposomes.

[0030] 3) Completely dissolving chitosan in an acid solution to obtain a chitosan solution, and dissolving sodium glycerophosphate in an aqueous solution containing a strong base and a weak acid salt to obtain a sodium glycerophosphate solution; the molecular weight of chitosan is 10,000-1,900,000 Da, the degree of deacetylation of chitosan is 45%-90%, and the concentration of the chitosan solution is 0.5%-2.5%; the sodium glycerophosphate is one or more of α-sodium glycerophosphate and β-sodium glycerophosphate, and the concentration is 5%-70%; the chitosan solution is chitosan dissolved in one or more of hydrochloric acid, acetic acid, and formic acid solutions, and the acid concentration is 0.01-0.4 mol / L, preferably 0.1-0.3 mol / L.

[0031] 4) Under ice bath conditions, sodium glycerophosphate solution is added dropwise to the chitosan solution and stirred for 5-30 minutes, and then active oxygen responsive drug-loaded liposomes are added and loaded into the gel by charge adsorption, finally obtaining an intelligent responsive chitosan gel system.

[0032] The concentration of the active oxygen responsive drug-loaded liposomes was calibrated by high performance liquid chromatography using the loaded drug, and its concentration was 0.01-1000 μg / ml.

[0033] The technical solution of the present invention is further described below through specific implementation cases in conjunction with the accompanying drawings of the specification, and the present invention is by no means limited to the embodiments. Example 1

[0034] Preparation of reactive oxygen species responsive drug-loaded liposomes: Dipalmitoylphosphatidylcholine, cholesterol, and distearoylphosphatidylethanolamine modified with ketalthiols and polyethylene glycol were dissolved in 6 mL of chloroform at a molar ratio of 85:10:5, and rotary evaporated at 50 °C for 30 minutes to obtain a phospholipid membrane. After adding 10 mL of calcium acetate solution to the flask to fully dissolve the film, it was hydrated at 65 °C for 1 hour. The obtained solution was reciprocally extruded 30 times with a 100 nm polycarbonate membrane and dialyzed for 12 hours. Then, the template drug diclofenac sodium was injected into the dialysis membrane and reacted at 60 °C for 30 minutes. The drug was loaded into the reactive oxygen species responsive liposomes using the pH gradient method, and the free drug was removed using a gel chromatography column to obtain the reactive oxygen species responsive drug-loaded liposomes. The concentration of the drug was determined by high performance liquid chromatography, and the concentration of the drug was adjusted to 10 ug / ml by ultrafiltration.

[0035] Preparation of intelligent responsive chitosan gel system: Dissolve 1 g of chitosan powder with a molecular weight of 120,000 Da and a deacetylation degree of 75% in a 0.08 mol / L dilute hydrochloric acid solution, stir to completely dissolve it, and obtain a chitosan solution with a concentration of 20 mg / mL, which is stored in an environment of 2-8 °C for more than 30 minutes. Dissolve sodium β-glycerophosphate in a 0.1 mol / L NaHCO3 solution to prepare a sodium β-glycerophosphate solution with a concentration of 60%, and store it in an environment of 2-8 °C for more than 30 minutes. Take 20 mL of chitosan solution, stir it in an ice bath, and add 4 mL of sodium β-glycerophosphate solution dropwise, and continue stirring for 15 minutes. Then, 0.8 mL of active oxygen responsive drug-loaded liposomes was compounded with the chitosan / β-sodium glycerophosphate precursor solution obtained above by charge adsorption in a ratio of chitosan solution, sodium glycerophosphate solution, and active oxygen responsive drug-loaded liposomes of 5:1:0.2, and finally an intelligent responsive chitosan gel system was obtained. Example 2

[0036] Preparation of reactive oxygen species responsive drug-loaded liposomes: Dipalmitoylphosphatidylcholine, cholesterol, and distearoylphosphatidylethanolamine modified with ketalthiols and polyethylene glycol were dissolved in 6 mL of chloroform at a molar ratio of 85:10:5, and rotary evaporated at 50 °C for 30 minutes to obtain a phospholipid membrane. After adding 10 mL of calcium acetate solution to the flask to fully dissolve the film, it was hydrated at 65 °C for 1 hour. The obtained solution was reciprocally extruded 30 times with a 100 nm polycarbonate membrane and dialyzed for 12 hours. Then, the template drug diclofenac sodium was injected into the dialysis membrane and reacted at 60 °C for 30 minutes. The drug was loaded into the reactive oxygen species responsive liposomes using the pH gradient method, and the free drug was removed using a gel chromatography column to obtain the reactive oxygen species responsive drug-loaded liposomes. The concentration of the drug was determined by high performance liquid chromatography, and the concentration of the drug was adjusted to 10 ug / ml by ultrafiltration.

[0037] Preparation of smart responsive chitosan gel system: Dissolve 1 g of chitosan powder with a molecular weight of 120,000 Da and a deacetylation degree of 75% in a 0.08 mol / L dilute hydrochloric acid solution, stir to completely dissolve it, and obtain a chitosan solution with a concentration of 20 mg / mL, which is stored in an environment of 2-8 °C for more than 30 minutes. Dissolve sodium β-glycerophosphate in a 0.1 mol / L NaHCO3 solution to prepare a sodium β-glycerophosphate solution with a concentration of 50%, and store it in an environment of 2-8 °C for more than 30 minutes. Take 20 mL of chitosan solution, stir it in an ice bath, and add 2 mL of sodium β-glycerophosphate solution dropwise, and continue stirring for 15 minutes. Then, 0.8 mL of active oxygen responsive drug-loaded liposomes was compounded with the chitosan / β-sodium glycerophosphate precursor solution obtained above by charge adsorption in a ratio of chitosan solution, sodium glycerophosphate solution, and active oxygen responsive drug-loaded liposomes of 5:0.5:0.2, and finally an intelligent responsive chitosan gel system was obtained. Example 3

[0038] Preparation of reactive oxygen species responsive drug-loaded liposomes: Dipalmitoylphosphatidylcholine, cholesterol, and distearoylphosphatidylethanolamine modified with ketalthiols and polyethylene glycol were dissolved in 6 mL of chloroform at a molar ratio of 85:10:5, and rotary evaporated at 50 °C for 30 minutes to obtain a phospholipid membrane. After adding 10 mL of calcium acetate solution to the flask to fully dissolve the film, it was hydrated at 65 °C for 1 hour. The obtained solution was reciprocally extruded 30 times with a 100 nm polycarbonate membrane and dialyzed for 12 hours. Then, the template drug diclofenac sodium was injected into the dialysis membrane and reacted at 60 °C for 30 minutes. The drug was loaded into the reactive oxygen species responsive liposomes using the pH gradient method, and the free drug was removed using a gel chromatography column to obtain the reactive oxygen species responsive drug-loaded liposomes. The concentration of the drug was determined by high performance liquid chromatography, and the concentration of the drug was adjusted to 10 ug / ml by ultrafiltration.

[0039] Preparation of smart responsive chitosan gel system: Dissolve 1 g of chitosan powder with a molecular weight of 120,000 Da and a deacetylation degree of 75% in a 0.1 mol / L dilute hydrochloric acid solution, stir to completely dissolve it, and obtain a chitosan solution with a concentration of 20 mg / mL, which is stored in an environment of 2-8 °C for more than 30 minutes. Dissolve sodium β-glycerophosphate in a 0.1 mol / L Na2CO3 solution to prepare a sodium β-glycerophosphate solution with a concentration of 60%, and store it in an environment of 2-8 °C for more than 30 minutes. Take 20 mL of chitosan solution, stir under ice bath conditions, and add 8 mL of sodium β-glycerophosphate solution dropwise, and continue stirring for 15 minutes. Then, 0.8 mL of active oxygen responsive drug-loaded liposomes are compounded with the obtained chitosan / sodium β-glycerophosphate precursor solution in a ratio of 5:2:0.2 of chitosan solution, sodium glycerophosphate solution, and active oxygen responsive drug-loaded liposomes by charge adsorption, and finally obtain smart responsive chitosan gel.

[0040] Table 1 is the osmotic pressure table of the smart chitosan system of Examples 1, 2, and 3: Example Osmol / L Example 1 439 Example 2 318 Example 3 647 It can be seen from this that the content of strong base, weak acid salt and sodium glycerophosphate can be adjusted to match the osmotic pressure of the body fluid inside the joint cavity, which is about 400 Osmol / L.

[0041] Comparative Example 1 Comparative Example 1 Compared with the steps of Example 1, the template drug diclofenac sodium was injected into the dialysis membrane for reaction at 60 ° C for 30 minutes, the drug was loaded into the active oxygen responsive liposomes by pH gradient method, and the free drug was removed by gel chromatography column to obtain active oxygen responsive drug-loaded liposomes. The concentration of the drug was determined by high performance liquid chromatography, and the concentration of the drug was adjusted to 10 ug / ml by ultrafiltration. The rest of the operation method was the same, and chitosan hydrogel without active oxygen responsive drug-loaded liposomes was prepared.

[0042] Comparative Example 1 was compared with Example 1 in tribological testing, and hyaluronic acid, a lubricant in human joints, was used as a reference object: the results showed that compared with sodium hyaluronate gel (HA), Comparative Example 1 showed that the friction coefficient of chitosan-sodium glycerophosphate gel (CS) was smaller. After the introduction of active oxygen responsive drug-loaded liposomes in Example 1, the friction coefficient of the smart responsive chitosan gel system (CS-Lip) was further reduced to 0.145, as shown in FIG. Figure 3 It is shown that in Example 1, active oxygen responsive drug-loaded liposomes are introduced into the composite hydrogel, which fully demonstrates that active oxygen responsive drug-loaded liposomes can enhance the lubrication effect of simple chitosan-sodium glycerophosphate gel.

[0043] Comparative Example 1 and Example 1 were compared in antioxidant test, with culture medium as blank group, hydrogen peroxide was used to simulate reactive oxygen stimulation, blank group, Comparative Example 1 and Example 1 were stimulated with reactive oxygen, and the cell activity of Comparative Example 1 and Example 1 groups was compared. The results showed that the cell activity of the blank group was significantly inhibited after the introduction of reactive oxygen stimulation, and although the cell activity was improved to a certain extent after the introduction of chitosan gel of Comparative Example 1, it was still lower than that of the group without reactive oxygen stimulation, and the cell activity was affected. After the introduction of Example 1, the activity of mesenchymal stem cells will not be affected before and after reactive oxygen stimulation, and the cell activity is higher than that of Comparative Example 1. This shows that the intelligent response chitosan hydrogel system can remove reactive oxygen and maintain cell activity, thereby achieving anti-inflammatory and antioxidant functions.

[0044] (1) Physicochemical characterization of reactive oxygen species-responsive drug-loaded liposomes a. Determination of particle size, polydispersity index (PDI) and Zeta potential Particle size and PDI value are very important for the quality and stability of liposomes. After the liposomes are diluted in a certain proportion, the hydrodynamic particle size, polydispersity index (PDI), and Zeta potential are measured using a projection electron microscope (TEM) and dynamic light scattering (DLS). The particle size of the active oxygen responsive drug-loaded liposomes is evenly distributed and spherical under an electron microscope, such as Figure 1 The results of the particle size and PDI of the drug-loaded liposomes responsive to active oxygen are shown in (a). Figure 1 As shown in Figure 1, at room temperature (about 25 °C), the particle size of the reactive oxygen species responsive liposomes is uniform and narrowly distributed, with an average particle size of 86.65 nm and an average PDI of 0.219, as shown in Figure 1 (c), indicating that the particle size distribution of the reactive oxygen species responsive drug-loaded liposomes is concentrated. In addition, the potentials of the reactive oxygen species responsive liposomes and the reactive oxygen species responsive drug-loaded liposomes are both between -35 and -40 mV, indicating that the loading of DS has no significant effect on the distribution of charge groups on the liposome surface, as shown in Figure 1 (b).

[0045] b. Responsiveness of liposomes to reactive oxygen species Hydrogen peroxide at a concentration of 100 uM was used to simulate the reactive oxygen environment of arthritis. The hydrodynamic diameter of the liposomes was measured by DLS after 60 minutes at 37 °C to investigate the changes in the liposome particle size under the reactive oxygen environment. The results showed that the liposome particle size increased significantly from 86.65 nm to 658.4 nm, and the PDI value increased to 0.683, as shown in Figure 1 (d). This result indicates that the liposomes respond to the simulated reactive oxygen environment, which helps the liposomes to disintegrate in the microenvironment of arthritis cells and quickly release the loaded drugs.

[0046] (2) Characterization of the physical and chemical properties of the intelligent responsive chitosan hydrogel system a. Microscopic morphology analysis: The hydrogel samples were frozen at -20 °C for 12 hours, freeze-dried for 24 hours, and then the small pieces were broken by liquid nitrogen and gold-sprayed. The cross-section of the hydrogel was scanned. The SEM of chitosan hydrogel showed that the morphology was an interconnected three-dimensional network porous structure. Figure 2 In (a), the cross-sectional pore structure of the chitosan hydrogel is looser, while the pore size of the gel system after the introduction of liposomes is smaller, and the network structure formed is denser, such as Figure 2 As shown in (b), it shows that liposomes can enhance the stability of chitosan gel.

[0047] b. Tribological testing: The tribological properties of the smart responsive chitosan gel system are the decisive factors in studying whether the hydrogel has an effective lubricating effect when applied to articular cartilage. The tribological test of the hydrogel system using a friction and wear tester showed that compared with sodium hyaluronate gel (HA), the friction coefficient of chitosan-sodium glycerophosphate gel (CS) was smaller, and after the introduction of liposomes, the friction coefficient of the smart responsive chitosan gel system (CS-LIP) was further reduced to 0.145. Figure 3 This indicates that in the chitosan hydrogel system, active oxygen responsive drug-loaded liposomes are introduced into the composite hydrogel, which fully demonstrates that active oxygen responsive drug-loaded liposomes can enhance the lubrication effect of simple chitosan-sodium glycerophosphate gel.

[0048] c. Gel conversion time: The composite solution of the precursor solution of the smart responsive chitosan gel system was placed in a centrifuge tube, immersed in a 37°C water bath, and the centrifuge tube was inverted for observation every 1 minute. Example 1 formed a stable solid form at 8 minutes, and Comparative Example 1 also formed a stable solid form at 10 minutes. Example 2 formed a stable solid form at 16 minutes. Example 3 formed a stable solid form at 14 minutes. It can be concluded that the concentrations of strong base, weak acid salt and sodium β-glycerophosphate can adjust the gelation time of the smart responsive chitosan hydrogel system.

[0049] d. Take 1g of the smart response chitosan hydrogel system and place it in an osmometer. The samples were tested three times in parallel to detect the average osmotic pressure of the smart response chitosan hydrogel system. This shows that the content of strong base, weak acid salt and sodium glycerol phosphate can be adjusted to match the osmotic pressure of the body fluid inside the joint cavity, which is about 400 Osmol / L.

[0050] (3) Cytotoxicity of smart response chitosan hydrogel system The biocompatibility of hydrogels plays a vital role in maintaining cell viability, proliferation and differentiation in tissue engineering. The CCK-8 assay was used to evaluate the effect of the smart response chitosan hydrogel system on the viability of rat-derived mesenchymal cells. A blank control group, a chitosan group, and a smart response chitosan hydrogel system group were set up, with 6 parallel wells in each group. The extracts of different groups of gel materials and the extracts containing 100 uM H2O2 were added to the well plates inoculated with cells. After 24 hours of culture, CCK-8 reagent was added, and the cells were incubated in the incubator for a certain period of time. The absorbance was measured at 450 nm by a microplate reader, and the cell survival rate (%) was calculated. The experimental results are shown in the figure. Figure 4 As shown, in Figure 4 In (a), the cell viability of the chitosan group and chitosan / liposome group was higher than that of the blank control group, indicating that chitosan had no obvious toxicity to cells. In addition, the blank group simulated reactive oxygen stimulation, and the results showed that the cell activity was significantly inhibited, while the cell activity was improved after the introduction of chitosan gel, and the activity of mesenchymal stem cells was not affected after the introduction of the liposome-loaded chitosan system. This shows that the liposome-loaded chitosan system can remove reactive oxygen and maintain cell activity. Figure 4 In (b), cells were grown in the presence of 50-500 μmol·L -1 After culturing for 24 hours in the extract of the intelligent response chitosan hydrogel system with different H2O2 concentrations, the results showed that there was no significant difference in cell viability and all had good cell activity. This shows that chitosan / liposomes can remove reactive oxygen in a wide range, thereby achieving anti-inflammatory and antioxidant functions.

[0051] (4) Drug release from smart responsive chitosan hydrogel system 3 g of the smart response chitosan hydrogel system was placed in 20 mL of phosphate buffer and phosphate buffer (PBS) containing 100 μM, respectively, and then placed in a 37 °C constant temperature shaker. 200 μL was taken every 0.5, 1, 2, 4, 8, 12, 24, 48, 72, 96, and 120 hours, and then 200 μL of the same phosphate buffer was added. Finally, the content of diclofenac sodium was detected at 278 nm by high performance liquid chromatography. The results showed that the release rate and amount of diclofenac sodium in the smart response chitosan hydrogel system under the action of hydrogen peroxide were higher than those in phosphate buffer, indicating that the gel system can use reactive oxygen to control the release of drugs, as shown in Figure 5.

[0052] The above is not a limitation of the present invention. It should be pointed out that for ordinary technicians in this technical field, several changes, modifications, additions or substitutions can be made without departing from the essential scope of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. An intelligent responsive chitosan gel system, characterized in that: The components of the chitosan gel system include active oxygen responsive drug-loaded liposomes, chitosan, sodium glycerophosphate and strong base and weak acid salt solutions.

2. The intelligent responsive chitosan gel system according to claim 1, characterized in that: The volume ratio of the chitosan solution, the sodium glycerophosphate solution and the active oxygen responsive drug-loaded liposome is (1-30): (0.1-3): (0-2).

3. A method for preparing an intelligent responsive chitosan gel system, characterized in that: The following steps are involved: 1) preparing reactive oxygen species-responsive liposome precursors, phospholipids, and cholesterol into reactive oxygen species-responsive liposomes by thin film hydration method; 2) The reactive oxygen species responsive liposomes are loaded with water-soluble anti-inflammatory drugs into the liposomes by the pH gradient method to obtain reactive oxygen species responsive drug-loaded liposomes; 3) dissolving chitosan completely in an acid solution to obtain a chitosan solution, and dissolving sodium glycerophosphate in an aqueous solution containing a strong base and a weak acid salt to obtain a sodium glycerophosphate solution; 4) Under ice bath conditions, sodium glycerophosphate solution was added dropwise to the chitosan solution, and then active oxygen responsive drug-loaded liposomes were added and loaded into the gel by charge adsorption, finally obtaining an intelligent responsive chitosan gel system.

4. The method for preparing the intelligent responsive chitosan gel system according to claim 3, characterized in that: The active oxygen responsive liposome precursor is thioketal-modified distearoylphosphatidylethanolamine and polyethylene glycol; the phospholipid is an anionic phospholipid, one or more of distearoylphosphatidylcholine, distearoylphosphatidylglycerol, distearoylphosphatidylethanolamine, and dipalmitoylphosphatidylcholine; the molar ratio of phospholipid, liposome precursor, and cholesterol in the active oxygen responsive liposome is (50%~95%): (1%~20%): (1%~20%).

5. The method for preparing the intelligent responsive chitosan gel system according to claim 3, characterized in that: The molecular weight of the chitosan is 10,000-1,900,000 Da, the deacetylation degree of the chitosan is 45%-90%, and the concentration of the chitosan solution is 0.5%-2.5%.

6. The method for preparing the intelligent responsive chitosan gel system according to claim 3, characterized in that: In the step 3), the sodium glycerophosphate is one or more of α-sodium glycerophosphate and β-sodium glycerophosphate, and the concentration is 5% to 70%.

7. The method for preparing the intelligent responsive chitosan gel system according to claim 3, characterized in that: In the step 3), the strong base and weak acid salt solution is one or more of sodium carbonate, sodium bicarbonate, sodium hydrogen phosphate, and disodium hydrogen phosphate, and the concentration is 0.01-0.4 mol / L.

8. The method for preparing the intelligent responsive chitosan gel system according to claim 3, characterized in that: The chitosan solution in step 3) is chitosan dissolved in one or more of hydrochloric acid, acetic acid, and formic acid solutions, and the acid concentration is 0.01-0.4 mol / L.

9. The method for preparing the intelligent responsive chitosan gel system according to claim 3, characterized in that: In the step 4), under ice bath conditions, sodium glycerophosphate solution is added dropwise to the chitosan solution; under ice-water mixed bath conditions, sodium glycerophosphate solution is added dropwise to the chitosan solution and stirred for 5-30 minutes.

10. The method for preparing the intelligent responsive chitosan gel system according to claim 3, characterized in that: The concentration of the active oxygen responsive drug-loaded liposomes is calibrated by high performance liquid chromatography using the loaded drug, and the concentration is 0.01-1000 μg / ml.

Citation Information

Patent Citations

  • Preparation method of in-situ nano composite hydrogel capable of controllably releasing medicine

    CN116370402A

  • Temperature-sensitive injectable tissue engineering scaffold suitable for cartilage and preparation method of temperature-sensitive injectable tissue engineering scaffold

    CN116942904A

  • Response liposome targeting CD44 loaded spinal cord injury repair drug and preparation method thereof

    CN118453899A

  • Sheet for display panel

    KR102124991B1

Cited By

  • Renewable boundary lubrication natural polyphenol anti-inflammatory hydrogel as well as preparation method and application thereof

    CN120771106A

  • ROS (reactive oxygen species) response type oil-water two-phase hydrogel as well as preparation method and application thereof

    CN120859929A

  • A biological superlubricity additive, a preparation method and application thereof

    CN123078730A